Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
48.03
-0.40 (-0.83%)
Jan 23, 2025, 12:33 PM EST - Market open
Soleno Therapeutics Employees
Soleno Therapeutics had 33 employees as of December 31, 2023. The number of employees increased by 8 or 32.00% compared to the previous year.
Employees
33
Change (1Y)
8
Growth (1Y)
32.00%
Revenue / Employee
n/a
Profits / Employee
-$3,974,667
Market Cap
2.07B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
SLNO News
- 5 weeks ago - Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC - GlobeNewsWire
- 2 months ago - Soleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 2 months ago - Soleno Therapeutics Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome - GlobeNewsWire
- 2 months ago - Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024 - GlobeNewsWire
- 3 months ago - Soleno Therapeutics Nears FDA Decision: Strong Buy Targeting PWS Hyperphagia Treatments - Seeking Alpha
- 3 months ago - SLNO Stock Rises as Prader-Willi Treatment Nears FDA Approval - GuruFocus
- 4 months ago - Janus Henderson Group PLC's Strategic Acquisition in Soleno Therapeutics Inc - GuruFocus
- 4 months ago - Soleno Therapeutics to Present at 2024 Cantor Global Healthcare Conference - GlobeNewsWire